nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Cefpodoxime—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Nausea—Topotecan—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Cefpodoxime—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000544	CcSEcCtD
Cefpodoxime—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000544	0.000544	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Cefpodoxime—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Cefpodoxime—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Cefpodoxime—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000535	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000535	0.000535	CcSEcCtD
Cefpodoxime—Nausea—Melphalan—peripheral nervous system neoplasm	0.000535	0.000535	CcSEcCtD
Cefpodoxime—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Cefpodoxime—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Cefpodoxime—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Cefpodoxime—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Cefpodoxime—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Cefpodoxime—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Cefpodoxime—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Cefpodoxime—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Cefpodoxime—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Cefpodoxime—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Cefpodoxime—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Cefpodoxime—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Cefpodoxime—Pain—Cisplatin—peripheral nervous system neoplasm	0.000503	0.000503	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Cefpodoxime—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Cefpodoxime—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Cefpodoxime—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Cefpodoxime—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Cefpodoxime—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Cefpodoxime—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Cefpodoxime—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Cefpodoxime—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Cefpodoxime—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Cefpodoxime—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Cefpodoxime—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Cefpodoxime—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Cefpodoxime—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Cefpodoxime—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Pain—Etoposide—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Cefpodoxime—Constipation—Etoposide—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Cefpodoxime—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Cefpodoxime—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Cefpodoxime—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Cefpodoxime—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Cefpodoxime—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Cefpodoxime—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Cefpodoxime—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Cefpodoxime—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Cefpodoxime—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Cefpodoxime—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Cefpodoxime—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Cefpodoxime—Rash—Vincristine—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Cefpodoxime—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Cefpodoxime—Headache—Vincristine—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00041	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Cefpodoxime—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Cefpodoxime—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Cefpodoxime—Nausea—Vincristine—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Cefpodoxime—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000387	0.000387	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Cefpodoxime—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Cefpodoxime—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Cefpodoxime—Rash—Cisplatin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Cefpodoxime—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Cefpodoxime—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Cefpodoxime—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Cefpodoxime—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Cefpodoxime—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Cefpodoxime—Rash—Etoposide—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Cefpodoxime—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Cefpodoxime—Headache—Etoposide—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Cefpodoxime—Nausea—Etoposide—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000282	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000231	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000223	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000222	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000217	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000214	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000206	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000198	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000192	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000185	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000176	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000176	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
